{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:51:55Z","timestamp":1792511515538,"version":"4.5.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Placement of an indwelling pleural catheter is an established modality for symptom relief and pleurodesis in the treatment of malignant pleural effusion. Concerns remain regarding possible infectious complications, risk of hemorrhage, and the rate of pleurodesis with the use of pleural catheters in the treatment of hematologic malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The goals of our study were: (1) to evaluate the safety and cumulative incidence of pleurodesis with indwelling pleural catheters for patients with hematologic malignancies, and (2) to evaluate overall survival of this cohort of patients with pleural effusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective review of 172 patients with a hematologic malignancy who underwent placement of an indwelling pleural catheter between September 1997 and August 2011 at the University of Texas MD Anderson Cancer Center in Houston, Texas. A competing risk model analysis was used for complications and pleurodesis. Analysis was based on each patient\u2019s first intrapleural catheter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 172 patients with lymphoma (58%), acute (16%) or chronic leukemia (16%), or multiple myeloma (10%). The effusions were characterized as malignant (85.5%), infectious (4.1%), volume overload (4.7%), or therapy-related (4.7%). Chylothorax was found in 20.1%. Pleural biopsies were obtained from 13 patients. The cumulative incidence of all complications was 13.6%, and the cumulative incidence of all significant catheter-related complications was 9.5%. The incidence of empyema was 2.9%, and major bleeding (requiring transfusion or intervention) was 1.7%. Thirty-day procedure-associated mortality was 0.6%. The cumulative incidence of pleurodesis at 180 days was 50%, with a median time to pleurodesis of 81 days for the entire cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Indwelling pleural catheters appear to be safe for patients with hematologic malignancies. Complications and the cumulative incidence of pleurodesis are comparable to those reported for patients with solid organ malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201610-785oc","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T11:56:00Z","timestamp":1490183760000},"page":"976-985","source":"Crossref","is-referenced-by-count":35,"title":["Indwelling Pleural Catheters for Patients with Hematologic Malignancies. A 14-Year, Single-Center Experience"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-3945","authenticated-orcid":false,"given":"Saadia A.","family":"Faiz","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Pathania","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care Medicine, and Sleep Medicine, The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7427-9388","authenticated-orcid":false,"given":"Diwakar D.","family":"Balachandran","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6351-5552","authenticated-orcid":false,"given":"David E.","family":"Ost","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo C.","family":"Morice","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5938-4841","authenticated-orcid":false,"given":"Vickie R.","family":"Shannon","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Bashoura","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6408-6964","authenticated-orcid":false,"given":"Georgie A.","family":"Eapen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"2026020403013062500_bib1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"key":"2026020403013062500_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/10428190500102845","article-title":"Malignant pleural effusion of multiple myeloma: prognostic factors and outcome","volume":"46","author":"Kamble","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"2026020403013062500_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/10428194.2012.713478","article-title":"Pleural effusions in patients with acute leukemia and myelodysplastic syndrome","volume":"54","author":"Faiz","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2026020403013062500_bib4","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1607::AID-CNCR16>3.0.CO;2-5","article-title":"Pleural effusion in patients with non-Hodgkin\u2019s lymphoma: a case-controlled study","volume":"83","author":"Elis","year":"1998","journal-title":"Cancer"},{"key":"2026020403013062500_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01695972","article-title":"Long-term outcome of follicular low-grade lymphoma: a report of 91 patients","volume":"66","author":"Morel","year":"1993","journal-title":"Ann Hematol"},{"key":"2026020403013062500_bib6","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1200\/JCO.1993.11.7.1336","article-title":"Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients","volume":"11","author":"Kirn","year":"1993","journal-title":"J Clin Oncol"},{"key":"2026020403013062500_bib7","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1378\/chest.125.4.1546","article-title":"Pleural effusions in hematologic malignancies","volume":"125","author":"Alexandrakis","year":"2004","journal-title":"Chest"},{"key":"2026020403013062500_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"2026020403013062500_bib9","first-page":"29","article-title":"Pulmonary disease in patients with hematologic malignancies","volume":"19","author":"Poletti","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403013062500_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1182\/asheducation-2009.1.80","article-title":"Immune hemolytic anemia--selected topics","volume":"2009","author":"Hoffman","year":"2009","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"2026020403013062500_bib11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1440-1843.2011.01986.x","article-title":"Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions","volume":"16","author":"MacEachern","year":"2011","journal-title":"Respirology"},{"key":"2026020403013062500_bib12","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"key":"2026020403013062500_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/JTO.0b013e3182114aa0","article-title":"Indwelling pleural catheter: changing the paradigm of malignant effusion management","volume":"6","author":"Lee","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026020403013062500_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1183\/09031936.00164706","article-title":"Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis","volume":"30","author":"Tremblay","year":"2007","journal-title":"Eur Respir J"},{"key":"2026020403013062500_bib15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/JTO.0b013e31820d614f","article-title":"Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters","volume":"6","author":"Suzuki","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026020403013062500_bib16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.athoracsur.2007.11.039","article-title":"Management of malignant pleural effusions using the Pleur(x) catheter","volume":"85","author":"Warren","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2026020403013062500_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1183\/16000617.0020-2016","article-title":"Advanced medical interventions in pleural disease","volume":"25","author":"Bhatnagar","year":"2016","journal-title":"Eur Respir Rev"},{"key":"2026020403013062500_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13063-015-0563-y","article-title":"The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial","volume":"16","author":"Bhatnagar","year":"2015","journal-title":"Trials"},{"key":"2026020403013062500_bib19","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1378\/chest.14-0394","article-title":"Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway","volume":"146","author":"Ahmed","year":"2014","journal-title":"Chest"},{"key":"2026020403013062500_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1378\/chest.11-2657","article-title":"Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion","volume":"142","author":"Fysh","year":"2012","journal-title":"Chest"},{"key":"2026020403013062500_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0003-4975(99)01482-4","article-title":"Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter","volume":"69","author":"Putnam","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"2026020403013062500_bib22","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"2026020403013062500_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1378\/chest.129.2.362","article-title":"Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion","volume":"129","author":"Tremblay","year":"2006","journal-title":"Chest"},{"key":"2026020403013062500_bib24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1378\/chest.14-3119","article-title":"The use of indwelling tunneled pleural catheters for recurrent pleural effusions in patients with hematologic malignancies: a multicenter study","volume":"148","author":"Gilbert","year":"2015","journal-title":"Chest"},{"key":"2026020403013062500_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/0003-4819-77-4-507","article-title":"Pleural effusions: the diagnostic separation of transudates and exudates","volume":"77","author":"Light","year":"1972","journal-title":"Ann Intern Med"},{"key":"2026020403013062500_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: an easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"2026020403013062500_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejso.2008.06.009","article-title":"Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis","volume":"35","author":"Sioris","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"2026020403013062500_bib28","doi-asserted-by":"crossref","first-page":"e000123","DOI":"10.1136\/bmjresp-2015-000123","article-title":"Complications of indwelling pleural catheter use and their management","volume":"3","author":"Lui","year":"2016","journal-title":"BMJ Open Respir Res"},{"key":"2026020403013062500_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/thx.2009.133504","article-title":"Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion","volume":"66","author":"Morel","year":"2011","journal-title":"Thorax"},{"key":"2026020403013062500_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/LBR.0000000000000001","article-title":"Infections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapy","volume":"20","author":"Mekhaiel","year":"2013","journal-title":"J Bronchology Interv Pulmonol"},{"key":"2026020403013062500_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11606-010-1472-0","article-title":"Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review","volume":"26","author":"Van Meter","year":"2011","journal-title":"J Gen Intern Med"},{"key":"2026020403013062500_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1513\/AnnalsATS.201411-511OC","article-title":"A quality improvement intervention to reduce indwelling tunneled pleural catheter infection rates","volume":"12","author":"Gilbert","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026020403013062500_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1062860612449475","article-title":"Detecting medical device complications: lessons from an indwelling pleural catheter clinic","volume":"28","author":"Casal","year":"2013","journal-title":"Am J Med Qual"},{"key":"2026020403013062500_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/LBR.0000000000000265","article-title":"Intrapleural fibrinolytic therapy in patients with nondraining indwelling pleural catheters","volume":"23","author":"Vial","year":"2016","journal-title":"J Bronchology Interv Pulmonol"},{"key":"2026020403013062500_bib35","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1378\/chest.12-3103","article-title":"Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study","volume":"144","author":"Fysh","year":"2013","journal-title":"Chest"},{"key":"2026020403013062500_bib36","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions: the ASAP trial","author":"Wahidi","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020403013062500_bib37","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0025-6196(26)01368-6","article-title":"The lipoprotein profile of chylous and nonchylous pleural effusions","volume":"55","author":"Staats","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"2026020403013062500_bib38","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIR.0000000000000105","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Fleisher","year":"2014","journal-title":"Circulation"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/6\/976\/66715706\/annalsats_14_6_976.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/6\/976\/66715706\/annalsats_14_6_976.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:01:43Z","timestamp":1770192103000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/14\/6\/976\/8453731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201610-785oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6]]},"published":{"date-parts":[[2017,6,1]]}}}